Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Geovax Labs (NQ: GOVX )

2.760 +0.030 (+1.10%)
Streaming Delayed Price Updated: 3:08 PM EDT, Sep 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 271,863
Open 2.690
Bid (Size) 2.710 (6)
Ask (Size) 2.760 (3)
Prev. Close 2.730
Today's Range 2.630 - 2.780
52wk Range 1.090 - 11.18
Shares Outstanding 2,172,309
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In August 2024 – Where Do Tesla, Nvidia, Apple, AMD Stock Rank?
A look at the top 20 most-searched tickers on Benzinga Pro for the month of August. 
Via Benzinga
GeoVax to Participate in Upcoming Investor Conferences in September
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire

Performance

YTD
-50.27%
-50.27%
1 Month
-61.40%
-61.40%
3 Month
+45.26%
+45.26%
6 Month
+37.31%
+37.31%
1 Year
-65.89%
-65.89%

More News

Read More
GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market
Via NewMediaWire
WHO Seeks $135M In Funding To Fight Mpox: Outbreak 'Can Be Controlled, And Can Be Stopped'
Via Benzinga
Snowflake, GeoVax, Zoom, Target, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Via Benzinga
Topics Stocks
Exposures US Equities
GeoVax Labs Stock Surges Ahead Of The Close, Shares Remain Volatile: What's Happening?
Via Benzinga
BioMedNewsBreaks — GeoVax Labs Inc. (NASDAQ: GOVX) Enters $8.5M Registered Direct Offering with Institutional Investor
Via Investor Brand Network
Exposures COVID-19
Registration is Now Open for Tribe Public's Webinar Event "Now Is Not the Time to Monkey(pox) Around" Featuring GeoVax Labs CEO
Via NewMediaWire
GeoVax Stock Is Tumbling Tuesday: What's Going On?
Via Benzinga
GeoVax Labs: Is This Micro-Cap Biotech Stock a Boom or a Bust?
Via MarketBeat
Exposures COVID-19
GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Why Bit Digital Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Virax Biolabs Shares Climb With Mpox Cases: What To Know
Via Benzinga
GeoVax Labs Stock Continues To Surge: What's Going On?
Via Benzinga
Why Xperi Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Are GeoVax Shares Trading Higher Today?
Via Benzinga
Emergent Biosolutions, Bavarian Nordic, GeoVax And SIGA Technologies Shares Are Making Big Moves Thursday: What's Going On?
Via Benzinga
GeoVax to Present at the Emerging Growth Conference on August 21, 2024
Via NewMediaWire
Exposures COVID-19
WHO Declares Mpox Public Health Emergency: 'Coordinated International Response Essential' To Halt Outbreak
Via Benzinga
GeoVax, SIGA Technologies Shares Soar After WHO Declares Mpox A Global Health Emergency
Via Benzinga
GeoVax Appoints Teresa Lambe, Acclaimed Professor of Vaccinology and Immunology at the Oxford Vaccine Group, to Its Scientific Advisory Board
Via NewMediaWire
Exposures COVID-19
GOVX Stock Earnings: Geovax Labs Beats EPS for Q2 2024
Via InvestorPlace
GeoVax Reports Second Quarter 2024 Financial Results and Provides Business Update
Via NewMediaWire
Exposures COVID-19
Update: GeoVax Announces Phase 2 Plans for Gedeptin Cancer Therapy Following Clinical Advisory Committee Review
Via NewMediaWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.